{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-042779","form_type":"8-K","ticker":"SYRA","cik":"0001922335","company_name":"Syra Health Corp","filed_at":"2024-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.354760+00:00","generated_at":"2026-05-30T09:25:13.883564+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Syra Health reports Q3 2024 revenue $2.3M (+42% YoY); net loss narrows 69% sequentially to $417K","bullets":["Revenue $2.3M, up 42% YoY from $1.6M; Population Health +36%, Healthcare Workforce +54%.","Net loss $417,535 ($0.06 EPS) vs $1.4M ($0.21) in Q2 2024, a 69% reduction quarter-over-quarter.","Gross margin improved to 29.7% from 17.8% in Q2 2024; operating expenses cut 37% sequentially.","Cash $2.7M with no long-term debt; management targets profitability in 2025.","Launched Syrenity mental health app; secured $5.8M Indiana training contract with revenue starting Q4 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-042779","json":"https://secwatch.observer/filing/0001493152-24-042779.json","markdown":"https://secwatch.observer/filing/0001493152-24-042779.md","text":"https://secwatch.observer/filing/0001493152-24-042779.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1922335/000149315224042779/0001493152-24-042779-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1922335/000149315224042779/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T09:25:13.883564+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}